Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
11.59
+1.43 (14.07%)
At close: Sep 26, 2025, 4:00 PM EDT
11.70
+0.11 (0.94%)
After-hours: Sep 26, 2025, 7:59 PM EDT
Immunome Market Cap
Immunome has a market cap or net worth of $1.01 billion as of September 26, 2025. Its market cap has increased by 16.18% in one year.
Market Cap
1.01B
Enterprise Value
744.96M
1-Year Change
16.18%
Ranking
Category
Stock Price
$11.59
Market Cap Chart
Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $1.01B, an increase of 805.69%. That is a compound annual growth rate of 55.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 1.01B | 52.20% |
| Dec 31, 2024 | 662.87M | 44.98% |
| Dec 29, 2023 | 457.21M | 1,605.70% |
| Dec 30, 2022 | 26.80M | -82.91% |
| Dec 31, 2021 | 156.82M | 53.68% |
| Dec 31, 2020 | 102.04M | -8.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.45B |
| Johnson & Johnson | 432.80B |
| AbbVie | 389.72B |
| UnitedHealth Group | 311.62B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 228.75B |